ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC79.62

C79.62

Billable

Secondary malignant neoplasm of left ovary

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C79.62 is a billable code used to indicate a diagnosis of secondary malignant neoplasm of left ovary.

Key Diagnostic Point:

C79.62 refers to a secondary malignant neoplasm of the left ovary, indicating that cancer has metastasized to the ovary from a primary site elsewhere in the body. This condition is often associated with advanced stages of cancer, where the primary tumor may be unknown or previously diagnosed. The left ovary, as a site of metastasis, may present with symptoms such as abdominal pain, bloating, or changes in menstrual cycles. Diagnosis typically involves imaging studies such as ultrasound or CT scans, along with histopathological examination of tissue samples. The management of secondary malignant neoplasms often focuses on palliative care, aiming to alleviate symptoms and improve quality of life, especially when the primary cancer is not amenable to curative treatment. Staging of the disease is crucial for determining prognosis and treatment options, and it may involve the use of the TNM classification system. Accurate coding of this condition is essential for appropriate treatment planning and reimbursement.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Determining the primary site of cancer can be challenging.
  • Need for precise documentation of metastatic disease.
  • Differentiating between primary and secondary neoplasms.
  • Staging considerations may complicate coding.

Audit Risk Factors

  • Inadequate documentation of the primary cancer site.
  • Failure to document staging details.
  • Misclassification of primary versus secondary neoplasms.
  • Lack of palliative care documentation.

Specialty Focus

Medical Specialties

Oncology

Documentation Requirements

Detailed history of the primary cancer, staging information, and treatment plans.

Common Clinical Scenarios

Patients with known primary cancers presenting with new ovarian masses.

Billing Considerations

Ensure clarity in distinguishing between primary ovarian cancer and metastatic disease.

Gynecology

Documentation Requirements

Comprehensive gynecological history and imaging results.

Common Clinical Scenarios

Evaluation of ovarian masses in patients with a history of cancer.

Billing Considerations

Documentation should reflect the multidisciplinary approach to treatment.

Coding Guidelines

Inclusion Criteria

Use C79.62 When
  • According to ICD
  • 10 coding guidelines, C79
  • 62 should be used when there is clear documentation of a secondary malignant neoplasm specifically in the left ovary
  • It is essential to ensure that the primary site is either known or documented as unknown
  • The code should not be used if the neoplasm is primary to the ovary

Exclusion Criteria

Do NOT use C79.62 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

58661CPT Code

Laparoscopy, surgical, with removal of ovary

Clinical Scenario

Used when a patient with a secondary malignant neoplasm undergoes surgical intervention.

Documentation Requirements

Document the indication for surgery and findings during the procedure.

Specialty Considerations

Oncology and gynecology should collaborate on documentation.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of secondary malignant neoplasms, improving the accuracy of cancer registries and treatment planning. C79.62 provides a clear distinction for coders to identify metastatic disease to the left ovary.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of secondary malignant neoplasms, improving the accuracy of cancer registries and treatment planning. C79.62 provides a clear distinction for coders to identify metastatic disease to the left ovary.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of secondary malignant neoplasms, improving the accuracy of cancer registries and treatment planning. C79.62 provides a clear distinction for coders to identify metastatic disease to the left ovary.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What is the significance of coding C79.62 accurately?

Accurate coding of C79.62 is crucial for appropriate treatment planning, reimbursement, and cancer registry reporting. It ensures that patients receive the necessary care and that healthcare providers are compensated for their services.